(Finance) – Eukedosa company listed on Euronext Milan which operates in the Italian healthcare and medical sector, closed on 2023 with a production value consolidated amount of 49.4 million, an increase compared to the 47 million euros recorded at the end of the previous financial year, a Gross Operating Margin consolidated amount of 12.3 million euros, in line with the result of 10.3 million recorded at 31 December 2022, and a useful equal to 556 thousand euros, compared to a profit of 443 thousand in 2022
There net financial position consolidated is negative for 103 million euros, compared to the negative 107 million at the end of 2022, and is significantly influenced by the impact of the accounting pursuant to IFRS 16 of lease contracts. The net financial position, adjusted for the impact of IFRS 16, would be equal to 16.6 million euros at 31 December 2023 and equal to 13.6 million euros at 31 December 2022.
(Photo: Priscilla Du Preez on Unsplash)